Jennifer Saville

Jennifer Saville is a Researcher and Scientific Lead at SA Pathology's National Referral Laboratory for lysosomal and related disorders, affiliated with the Adelaide Medical School at the University of Adelaide. She specializes in biochemical assessment of rare diseases, particularly using mass spectrometry to study substrate accumulation and neurodegenerative mechanisms. Her work focuses on improving diagnostic algorithms and understanding lipid roles in neurological decline.

Education & Affiliations:

• Scientific Lead at SA Pathology's National Referral Laboratory
• Adelaide Medical School, Faculty of Health and Medical Sciences

Research Interests:

Her research emphasizes lysosomal storage disorders, rare disease diagnostics, and lipid metabolism's impact on neurodegeneration. She leads implementation of diagnostic tests to enhance accuracy and speed, with a focus on biomarkers for diseases like Gaucher, Pompe, and MPS types I, IIIA, and IVA.

Publications:

Recent work includes studies on sphingolipid metabolism in Gaucher disease, lipid biomarkers in neurodegeneration, and RNA-based therapies for Fabry disease. These publications highlight her focus on translational research and diagnostic innovation.

Awards & Grants:

No explicit awards mentioned, but her contributions to diagnostic advancements and lipid research are significant. She collaborates with institutions like SA Pathology and the University of Adelaide.

Advising & Teamwork:

Co-supervisor for PhD student Ashleigh Lake (project: Gaucher disease cell pathology). Mentored multiple placement, honors, and master's students. Active member of the Australian and New Zealand Society for Mass Spectrometry since 2007.

Labs & Teams:

Works under Professor Maria Fuller's guidance, focusing on lysosomal disorders. Collaborates with international teams on lipid profiling and biomarker development.